92 related articles for article (PubMed ID: 6221576)
1. Urinary excretion of prostaglandins and thromboxanes in the hepatorenal syndrome.
Kronborg IJ; Radvan G; Zipser RD
Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():539-42. PubMed ID: 6221576
[No Abstract] [Full Text] [Related]
2. Urinary thromboxane B2 and prostaglandin E2 in the hepatorenal syndrome: evidence for increased vasoconstrictor and decreased vasodilator factors.
Zipser RD; Radvan GH; Kronborg IJ; Duke R; Little TE
Gastroenterology; 1983 Apr; 84(4):697-703. PubMed ID: 6572162
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic trial of thromboxane synthesis inhibition in the hepatorenal syndrome.
Zipser RD; Kronborg I; Rector W; Reynolds T; Daskalopoulos G
Gastroenterology; 1984 Dec; 87(6):1228-32. PubMed ID: 6593268
[TBL] [Abstract][Full Text] [Related]
4. [Urinary prostaglandins in the hepatorenal syndrome of cirrhotic patients: role of thromboxane A2 and an imbalance of precursor polyunsaturated fatty acids].
Parelon G; Mirouze D; Michel F; Crastes de Paulet P; Chaintreuil J; Crastes de Paulet A; Michel H
Gastroenterol Clin Biol; 1985 Apr; 9(4):290-7. PubMed ID: 3996812
[TBL] [Abstract][Full Text] [Related]
5. Radiation-induced alterations in prostaglandin excretion in the rat.
Donlon M; Steel L; Helgeson EA; Shipp A; Catravas GN
Life Sci; 1983 Jun; 32(23):2631-9. PubMed ID: 6343746
[TBL] [Abstract][Full Text] [Related]
6. Presence of thromboxane B2 and 6-keto-prostaglandin F1 alpha in the urine of fetal sheep.
Walker DW; Mitchell MD
Prostaglandins Med; 1979 Oct; 3(4):249-50. PubMed ID: 583578
[No Abstract] [Full Text] [Related]
7. Urinary excretion of prostaglandin E2, prostaglandin F2 alpha, and thromboxane B2 in normotensive and hypertensive subjects on varying sodium intakes.
Campbell WB; Holland OB; Adams BV; Gomez-Sanchez CE
Hypertension; 1982; 4(5):735-41. PubMed ID: 7049923
[No Abstract] [Full Text] [Related]
8. Prevention of acute cyclosporine A nephrotoxicity by a thromboxane synthetase inhibitor.
Smeesters C; Chaland P; Giroux L; Moutquin JM; Etienne P; Douglas F; Corman J; St-Louis G; Daloze P
Transplant Proc; 1988 Apr; 20(2 Suppl 2):663-9. PubMed ID: 3163209
[No Abstract] [Full Text] [Related]
9. Evidence for a renal origin of urinary thromboxane B2 in health and disease.
Patrono C; Ciabattoni G; Patrignani P; Filabozzi P; Pinca E; Satta MA; van Dorne D; Cinotti GA; Pugliese F; Pierucci A; Simonetti BM
Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():493-8. PubMed ID: 6221569
[No Abstract] [Full Text] [Related]
10. Urinary prostaglandin E2 in chronic renal disease.
Ruilope L; Bernis C; Garcia-Robles R; Alcazar J; Barrientos A; Tresguerres JA; Rodicio J
Clin Nephrol; 1981 Oct; 16(4):215. PubMed ID: 6945927
[No Abstract] [Full Text] [Related]
11. [A solid phase direct radioimmunoassay for urinary thromboxane B2 and its clinical application].
Uehara Y; Doi M; Kobayashi T; Takagi M; Ishii M; Sugimoto T
Nihon Jinzo Gakkai Shi; 1984 Oct; 26(10):1301-8. PubMed ID: 6527429
[No Abstract] [Full Text] [Related]
12. A new radioimmunoassay for urinary thromboxane B2 with prior purification by high performance liquid chromatography.
Geoffroy J; Benzoni D; Sassard J
Prostaglandins Leukot Med; 1985 Jun; 18(3):393-9. PubMed ID: 3860880
[TBL] [Abstract][Full Text] [Related]
13. Urine thromboxane as an immunologic monitor in kidney transplant patients.
Foegh ML; Alijani M; Helfrich GB; Schreiner GE; Ramwell PW
Transplant Proc; 1984 Dec; 16(6):1603-5. PubMed ID: 6390872
[No Abstract] [Full Text] [Related]
14. Preparation of 2,3,4,5-tetranor-thromboxane B2, the major urinary catabolite of thromboxane B2 in the rat.
Pace-Asciak CR; Edwards NS
Methods Enzymol; 1982; 86():604-7. PubMed ID: 7132772
[No Abstract] [Full Text] [Related]
15. Urinary thromboxane B2 on allograft rejection.
Mahoney DA; Barden AE; Vandongen R; Hurst P; Banks R; Beilin LJ; Saker B; Thatcher G
Lancet; 1981 Nov; 2(8254):1046. PubMed ID: 6118500
[No Abstract] [Full Text] [Related]
16. Urinary prostaglandins in sickle cell nephropathy: a defect in 9-ketoreductase activity?
de Jong PE; Saleh AW; de Zeeuw D; Donker AJ; van der Hem GK; Pratt JJ; Sewrajsingh GS; Statius van Eps LW
Clin Nephrol; 1984 Oct; 22(4):212-3. PubMed ID: 6595096
[No Abstract] [Full Text] [Related]
17. Increase in urinary thromboxane B2 in rats caused by cyclosporine.
Kawaguchi A; Goldman MH; Shapiro R; Foegh ML; Ramwell PW; Lower RR
Transplantation; 1985 Aug; 40(2):214-6. PubMed ID: 4024243
[No Abstract] [Full Text] [Related]
18. Tetranor thromboxane B2 is the principal urinary catabolite formed after i.v. infusion of thromboxane B2 in the rat.
Pace-Asciak CR; Edwards NS
Biochem Biophys Res Commun; 1980 Nov; 97(1):81-6. PubMed ID: 7458943
[No Abstract] [Full Text] [Related]
19. Monitoring of rat heart allograft rejection by urinary thromboxane.
Foegh ML; Khirabadi BS; Shapiro R; Alijani MR; Goldman MH; Lower RR; Ramwell PW
Transplant Proc; 1984 Dec; 16(6):1606-8. PubMed ID: 6390873
[No Abstract] [Full Text] [Related]
20. Urinary prostaglandin-E2 in chronic renal disease.
Blum M; Bauminger S; Algueti A; Kisch E; Ayalon D; Aviram A
Clin Nephrol; 1981 Feb; 15(2):87-9. PubMed ID: 7214757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
